Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Heart Lung Transplant. 2016 Jul 15;35(11):1295–1302. doi: 10.1016/j.healun.2016.06.022

Table 3.

CEC Association With Change in MIT or TAV as Measured by IVUS

β for CEC R2 p-value
MIT adjustment variables
  Baseline MIT −0.23 0.25 0.022
  HDL-C −0.34 0.10 0.023
  Clinical characteristics −0.29 0.21 0.047
TAV adjustment variables
  Baseline MIT −0.25 0.18 0.019
  HDL-C −0.39 0.10 0.009
  Clinical characteristics −0.37 0.21 0.014

Standardized β-coefficients are presented for cholesterol efflux capacity (CEC), adjusted for baseline maximal intimal thickness (MIT) or total atheroma volume (TAV), high-density lipoprotein cholesterol (HDL-C) or additional clinical variables, including donor and recipient age, gender, race, cytomegalovirus (CMV) status and recipient diabetes. Clinical variables include donor and recipient age, gender, race, CMV status, recipient diabetes and HDL-C. IVUS, intravascular ultrasound.